Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,641 public trials 502 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.

NCT01070862

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CHU CAEN Dept of Hematology Caen, France

CHU Henri Mondor Créteil, France

CHU Saint Louis Dept of Hematology Paris, France

View Trial Details

Completed

The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma

NCT00459069

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

NCT00229203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Jerome Lipper Multiple Myeloma Center - Dept of Medical Oncology - Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

NCT00988312

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Hospital Dresden Dresden, Germany

View Trial Details

Completed

Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

NCT00425347

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Arkansas Cancer Research Center Little Rock, Arkansas, United States

USC/Norris Cancer Hospital Los Angeles, California, United States

Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

NCT00051116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Myeloma Institute University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma

NCT00391157

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Clínic Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital Germans Trias i Pujol Barcelona, Spain

Hospital Clínico San Carlos de Madrid Madrid, Spain

View Trial Details

Completed

GEM05 for Patients With Multiple Myeloma Under 65 Years

NCT00461747

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital Royo Villanova Zaragoza, Aragon, Spain

Hospital Ntra. Sra. Sonsoles Ávila, Avila, Spain

Xarxa assistencial de Manresa Manresa, Barcelona, Spain

View all 79 locations

View Trial Details

Completed

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

NCT00186316

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients

NCT00327249

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Investigational Site 025 Little Rock, Arkansas, United States

Investigational Site 008 Houston, Texas, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions